tallózása szerző szerint "Hadzic N"

1-8 / 8

Diagnosis and Management of Pediatric Autoimmune Liver Disease: ESPGHAN Hepatology Committee Position Statement

Mieli-Vergani G; Vergani D; Baumann U; Czubkowski P; Debray D; Dezsőfi, Antal; Fischler B; Gupte G; Hierro L; Indolfi G; Jahnel J; Smets F; Verkade HJ; Hadzic N (2018)

Paediatric autoimmune liver disease is characterized by inflammatory liver histology, circulating autoantibodies, and increased levels of IgG, in the absence of a known etiology. Three conditions have a likely autoimmune ...
Early and late factors impacting patient and graft outcome in pediatric liver transplantation: summary of an ESPGHAN Monothematic Conference

McLin VA; Allen U; Boyer O; Bucuvalas J; Colledan M; Cuturi MC; d'Antiga L; Debray D; Dezsőfi, Antal; Goyet JV; Dhawan A; Durmaz O; Falk C; Feng S; Fischler B; Franchi-Abella S; Frauca E; Ganschow R; Gottschalk S; Hadzic N; Hierro L; Horslen S; Hubscher S; Karam V; Kelly D; Maecker-Kolhoff B; Mazariegos G; McKiernan P; Melk A; Nobili V; Ozgenc F; Reding R; Sciveres M; Sharif K; Socha P; Toso C; Vajro P; Verma A; Wildhaber BE; Baumann U (2017)

As pediatric liver transplantation comes of age, experts gathered to discuss current paradigms and define gaps in knowledge warranting research to further improve patient and graft outcomes. Identified areas ripe for ...
Hepatic neoplasms in children: A focus on differential diagnosis.

Dezsőfi, Antal; McLin V; Hadzic N (2014)

Paediatric hepatic neoplasias are rare, accounting for 1-4% of all solid childhood tumors. Liver tumors in children can be classified into benign or malignant; some of the benign lesions can have the potential of malignant ...
Hepatitis E in Children: A Position Paper by the ESPGHAN Hepatology Committee.

Fischler B; Baumann U; Dezsőfi, Antal; Hadzic N; Hierro L; Jahnel J; McLin V; Nobili V; Smets F; Verkade H; Debray D (2016)

BACKGROUND: Hepatitis E virus (HEV) is endemic in large parts of the developing world. Waterborne transmission of genotypes 1 or 2 commonly causes acute hepatitis, which is usually self-limited in healthy individuals. In ...
Indications and limitations of bariatric intervention in severely obese children and adolescents with and without nonalcoholic steatohepatitis: ESPGHAN Hepatology Committee Position Statement.

Nobili V; Vajro P; Dezsőfi, Antal; Fischler B; Hadzic N; Jahnel J; Lamireau T; McKiernan P; McLin V; Socha P; Tizzard S; Baumann U (2015)

Morbid obesity is strongly associated with nonalcoholic fatty liver disease (NAFLD), which is one of the most common causes of chronic liver disease worldwide. The present best treatment for NAFLD and nonalcoholic ...
Liver biopsy in children: position paper of the ESPGHAN Hepatology Committee

Dezsőfi, Antal; Baumann U; Dhawan A; Durmaz O; Fischler B; Hadzic N; Hierro L; Lacaille F; McLin VA; Nobili V; Socha P; Vajro P; Knisely AS (2015)

Liver biopsy (LB) is still the criterion standard procedure for obtaining liver tissue for histopathological examination and a valuable tool in the diagnosis, prognosis, and management of many parenchymal liver diseases. ...
The Health Care Transition of Youth With Liver Disease Into the Adult Health System: Position Paper From ESPGHAN and EASL

Vajro P; Fischler B; Burra P; Debray D; Dezsőfi Antal; Nuzio SG; Hadzic N; Hierro L; Jahnel J; Lamireau T; McKiernan P; McLin V; Nobili V; Socha P; Smets F; Baumann U; Verkade HJ (2018)

Background: Medical advances have dramatically improved the long-term prognosis of children and adolescents with once-fatal hepatobiliary diseases. However, there is no generally accepted optimal pathway of care for the ...
Treatment of Chronic Hepatitis C Virus Infection in Children: A Position Paper by the Hepatology Committee of European Society of Paediatric Gastroenterology, Hepatology and Nutrition

Indolfi G; Hierro L; Dezsőfi, Antal; Jahnel J; Debray D; Hadzic N; Czubowski P; Gupte G; Mozer-Glassberg Y; van der Woerd W; Smets F; Verkade HJ; Fischler B (2018)

Objectives: In 2017, the European Medicines Agency and the Food and Drug Administration approved the use of the fixed-dose combination of ledipasvir/sofosbuvir and of the combination of sofosbuvir and ribavirin for treatment ...

1-8 / 8

Keresés

Összetett keresés

Tallózás

Teljes repozitórumban

Hozzáférésem

Bejelentkezés

tallózása szerző szerint "Hadzic N"

DSpace/Manakin Repository

tallózása szerző szerint "Hadzic N"

Keresés

Tallózás

Teljes repozitórumban

Hozzáférésem